21st European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
27th International Congress of Chemotherapy (ICC)
07.05.2011 - 10.05.2011
Please select a day:
07.05.2011
08.05.2011
09.05.2011
10.05.2011
Publication only
Search

Personal programme
Please enter your email address here in order to bring up your personal programme




Home


Sunday, May 08, 2011

- Click on a checkbox to select a whole session.
- Session titles which are underlined can be clicked upon to show further details.
- Individual programme items can also be selected.
- Go to another day to select further points or click on display to show your saved personal programme.
07:45 EUCAST disk diffusion test - frequently asked questions (Meet-the-Expert)
07:45 Standardisation of molecular diagnostics in virology (Meet-the-Expert )
07:45 PK/PD for non-experts (Meet-the-Expert )
07:45 Zoonoses for the non-initiated: when to suspect them, how to diagnose them, how to treat them (Meet-the-Expert)
07:45 MALDI-TOF identification (fungi, bacteria, viruses, cell cultures) (Meet-the-Expert )
07:45 Making research and reporting better using the ORION statement to design or evaluate infection control intervention studies and outbreak reports (Meet-the-Expert)
09:00 Genetics and epidemiology of mobile resistance: mobilome and resistome (Official Symposium)
09:00 New aspects of antimicrobial treatment of anaerobic infections (Official Symposium)
09:00 Q fever: a major threat in Europe (Official Symposium)
09:00 Opportunistic infections in solid organ transplant recipients (Official Symposium)
09:00 Can we decrease hospital-acquired infections in ''real'' life? (Oral session)
09:00 What is changing in the invasive mycosis field? (Oral session)
09:00 The Big Question – are we staying ahead of antibiotic resistance in the hospital setting? (Astellas Symposium)
09:00 New challenges for the infectious disease laboratory (Siemens Symposium)
09:00 Current and future perspectives in clinical diagnosis of viral, bacterial, parasites and fungal pathogens using a unique multiplexing technology (Luminex Integrated Symposium)
09:00 New updates on the management of MRSA nosocomial infections (Pfizer Symposium)
11:30 Challenges in making a TB vaccine (Keynote Lecture)
11:30 Prospects for the control of neglected tropical diseases (Keynote Lecture)
11:30 Amoeba as genitor of new pathogenic microorganisms (Keynote Lecture)
11:30 The disease and death of Enrico Caruso, Italian tenor (Keynote Lecture)
11:30 Antifungal drugs make me mad: candins or azoles (Official Symposium)
11:30 Viral resistance testing - where are we? (Official Symposium)
11:30 Pro vs Con: guideline vs. clinical practice-driven strategies in treating severe infectious diseases (Official Symposium)
11:30 The year in infectious diseases (Official Symposium)
11:30 Biofilm: from pathogenesis to preventive measures (Oral session)
11:30 Antimicrobial activity of different antibiotics alone or in combination against MDR Gram-negative rods (Oral session)
12:30
POSTER SESSION II
12:30 MRSA: trend, surveillance, genetic characterisation (Poster topic 18)
12:30 Travel medicine: tropical and parasitic diseases (Poster topic 19)
12:30 MRSA in animals (Poster topic 20)
12:30 Molecular tools for Staphylococus aureaus: from epidemiology to diagnosis (Poster topic 21)
12:30 Enterococci (Poster topic 22)
12:30 Coagulase-negative staphylococci (Poster topic 23)
12:30 AMR in Gram-positives (Poster topic 24)
12:30 Pneumococci (Poster topic 25)
12:30 Streptococci: from diagnosis to pathogenesis (Poster topic 26)
12:30 AMR in fastidious micro-organisms (Poster topic 27)
12:30 Emerging infectious diseases (Poster topic 28)
12:30 Detection of resistance in Gram-positive bacteria (Poster topic 29)
12:30 Antimicrobial resistance (Poster topic 30)
12:30 New insights on mechanisms of resistance in Staphylococcus aureus (Poster topic 31)
12:30 Experimental treatments in vivo (Poster topic 32)
12:30 Miscellaneous infections (Poster topic 33)
12:30 Miscellaneous antimicrobial resistance (Poster topic 34)
13:30
POSTER SESSION III
13:30 Reporting nosocomial infections - Where are we? (Poster topic 35)
13:30 Risk factors for nosocomial infections: how many are modifiable? (Poster topic 36)
13:30 Tigecycline (Poster topic 37)
13:30 New antimicrobials in vitro activity (Poster topic 38)
13:30 New non-conventional antimicrobials (no drugs) (Poster topic 39)
13:30 New targets for new antimicrobials (Poster topic 40)
13:30 Antimicrobial activity of different antibiotics alone or in combination against MDR Gram-negative rods (Poster topic 41)
13:30 Carbapenems (Poster topic 42)
13:30 Quinolones (Poster topic 43)
13:30 H1N1 (Poster topic 44)
13:30 HAI and environmental contamination (Poster topic 45)
13:30 Nosocomial infection (Poster topic 46)
13:30 Outbreaks (Poster topic 47)
13:30 MRSA - colonisation and screening (Poster topic 48)
13:30 Measuring and influencing community antibiotic use (Poster topic 49)
13:30 Antibiotic use, stewardship and resistance in the hospital: optimising outcomes (Poster topic 50)
13:30 Surveillance systems (Poster topic 51)
13:30 Infection control (Poster topic 52)
13:30 Epidemiology of antimicrobial resistance (Poster topic 53)
13:30 Hand hygiene (Poster topic 54)
14:30
AFTERNOON SESSIONS
14:30 ESCMID Excellence Award (Keynote Lecture)
14:30 Antibiotic resistance: back to the bigger circle (Keynote Lecture)
14:30 Metagenomics and detection of new viruses (Keynote Lecture)
14:30 The year in infection control (Official Symposium)
14:30 Are probiotics growth promoters in humans? (Official Symposium)
14:30 Eradication of malaria (Official Symposium)
14:30 Antifungal management strategies (Official Symposium)
14:30 Molecular bacteriology: insight in the virulence of Gram-positive cocci (Oral session)
14:30 Genetics of NDM-1 (Oral session)
14:30 Epidemiology of cholera: experience from the cholera epidemics in Haiti (Keynote Lecture)
16:00 European preparedness and response to highly infectious diseases (Official Symposium)
16:00 The role of PK/PD for choosing antifungal drugs (Official Symposium)
16:00 Antibiotic combination interactions (Official Symposium)
16:00 The future of hospital antibiotic stewardship - what should we achieve by 2020? (Official Symposium)
16:00 Influenza H1N1 pandemic and complications (Oral session)
16:00 Mycobacterial disease to Epi and beyond (Oral session)
16:00 Bad bugs need better drugs: addressing the global challenge (Astra-Zeneca Symposium)
16:00 Diagnosis of bloodstream infections (BSI): present and future (bioMérieux Symposium)
16:00 Bad bugs, which drugs? Superior potency for better outcomes in Gram-positive infections (Novartis Symposium)
16:00 Pneumococcal disease in adults: a remaining challenge (Pfizer Symposium)